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Summary.-The carcinogenic effects of dimethylnitrosamine (DMN) and nitro-
somethylurea (NMU) injected subcutaneously at 3 different dose levels in European
hamsters were studied. DMN induced malignant haemangioendotheliomata of the
liver and kidney, hepatocellular carcinomata and, in one animal, a cholangiocellular
carcinoma. The effect of NMU was localized at the site ofadministration and resulted
in subcutaneous fibrosarcomata, carcinosarcomata or epidermal carcinomata.
IN ANIMAL experiments, the nitroso
compounds dimethylnitrosamine (DMN)
and nitrosomethylurea (NMU), both
thought to react through the same
metabolic pathway (Magee, 1973), show
strong carcinogenic effects. Molecular
alterations of certain cell constituents,
partioularly nucleic acids and proteins,
are considered to be responsible for these
effects. The results obtained may vary
among species due to the biological
response of the animals to the carcino-
genic interactions. This study involves
the investigation of the carcinogenic
effects of both DMN and NMU in the
European hamster (Cricetus cricetus L.), a
new animal model in cancer research.
MATERIALS AND METHODS
Wild European hamsters of unknown age
(40 males, average body weight, 255 g and
40 females, average body weight, 185 g) were
captured in Niedersachsen, West Germany.
Thirty males and 30 females were divided
into 6 equal groups, each group receiving
weekly subcutaneous injections of either 0 2,
0-1 or 0-05 of the LD50 of DMN or NMU in
physiological saline. The LD50 was deter-
mined according to the method of Weil
(1952). The controls, 10 males and 10
females, received the solvent for DMN and
NMU once weekly for life. The animals were
maintained under standard laboratory con-
ditions until death; they were housed
individually in Makrolon cages Type III,
room temperature, 22 + 1°C; relative humi-
dity, 55 + 5%; air exchange, 8 times/h,
and were given a p0lleted diet (Hope Farms
RMH-TMB) and water ad libitum. Complete
autopsies were performed on all animals and
the organs were fixed in 500 buffered for-
malin. Paraplast sections were stained with
haematoxylin and eosin and van Gieson
stain. To examine the nasal cavities and the
brain, all skulls were decalcified with Dekal
(Scientific Products, Evanston, Illinois). One
week after the last carcinogen treated animal
had died, the remaining controls Mwere
sacrificed using ether (Pro narcosi, Hoechst).
RESULTS
The LD50 of DMN given to females
was 43 mg/kg body weight and for males
28 mg/kg; its 95 of 100 confidence interval
was estimated as 9 mg/kg and 6 mg/kg
respectively. In the case of NMU, there
was no difference in the LD50 value
between males andfemales: 113mg/kgb.w.
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was the LD50 with a 95% confidence
level ± 26 mg/kgb.w.
In the control group, 3 males devel-
oped spontaneous tumours: 2 papillomata
of the forestomach and one adenoma of
the adrenal cortex. They were found
between the 38th and 45th weeks after
beginning the experiment.
Dimethylnitrosamine (DMN)
The results of DMN application are
summarized in the Table. There were
statistically significant differences in sur-
vival rates dependent upon the dosage of
the group (P < 0.05). The first tumour,
a squamous cell carcinoma in the apical
region of the nasal cavity, appeared in a
female of the group given 0-2 of the
LD50, 13 weeks after initial application,
while the earliest neoplasms of the liver
appeared after 24 weeks and the earliest
kidney tumour after 28 weeks. Both
tumours developed in females of the
0*05 of the LD50 dosage group. Histo-
logically, the liver tumours found were
of either vascular (10) or hepatocellular (5)
origin; one tumour showed a mixed
pattern with vascular and hepatocellular
parts; in addition, a cholangiocellular
carcinoma was found. All neoplasms
were malignant, with infiltration of the
parenchyma and sometimes of the sur-
rounding organs (peritoneum, pancreas,
spleen, intestine). The vascular neo-
plasms were diagnosed as malignant
haemangioendotheliomata or angiosarco-
mata (Fig. 1); three metastasized to the
lungs. The hepatocellular carcinomata
were characterized by an arrangement of
tumour cells found surrounding extensive
bleeding parts. Regions with fatty de-
generation, necroses of liver cells and
proliferation of the bile ducts were
encountered regularly in all liver neo-
plasms.
Kidney tumours were observed more
frequently in females than in males.
These neoplasms were also classified as
malignant haemangioendotheliomata or
angiosarcomata of a well defined vascular
nature (Fig. 2); endothelial cells which
TABLE.-Results of DMN and NMU Carcinogenesis in the European Hamster
(Cricetus cricetus L)
Malignant tumours
Average Tumour, A
survival bearing Admin. Other tumours
Dose Sex (weeks) animals Liver Kidney site (Animal-No.)
0.2 LD50 o 10 1/10 Squamous cell carcinoma of
nasal cavity (1)
0.1 LD50 9 26 5/10 3 - - Malignant lymphoma (1)
Rhabdomyosarcoma of
diaphragm (1)
0-5 LD5s ? 33 10/10- 8 5 - Malignant lymphoma (1)
Leiomyosarcoma of small
intestine (1)
Papilloma offorestomach (1)
0-2 LD5do 17 1/10 - Adenoma of lungs and
papilloma offorestomach
0- ILD5o o 32 6/10 5 1 - Malignant schwannoma
0 05 LD50 d 39 6/10 1 2 Papilloma of forestomach (2)
abdominal sarcoma (1)
0-2 LD50 o 13 4/10 - 4 Papilloma of forestomach (1)
0.1 LD50 S 22 7/10 - 7
0-05 LD50
0-2 LD5o
0-1 LD50
I
CT
28
12
18
9/10
2/10 ,
7/10
9
-- 1 Malignant lymphoma
- - 7 Neurosarcoma in the heart
(2)
Papilloma of forestomach (2)
Squamous cell carcinoma
side of head (2)
9 Malignant lymphoma (1)
Papilloma offorestomach (1)
Compound
DMN
N-MU
0.05 LD50 , 30 10/10
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FIG. 1.-Malignant haemangioendothelioma of the liver found in a female treated with 0-05 of the
LD5o 40 weeks after beginning treatment with DMN. H. & E. x 150.
FIG. 2.-Malignant haemangioendothelioma ofthe kidney seen in a male European hamster injected
with 0.05 of the DMN LD5o after 52 weeks of treatment. H. & E. x 180.
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FIG. 3.-This subcutaneous fibrosarcoma was identified in a female hamster after 23 weeks of
treatment with 0 1 ofthe NMU LD50. H. & E. x 150.
FIG. 4.-Epidermal carcinoma with distinct cornification seen in a female European hamster 30
weeks after beginning treatment with 0-2 of the NMU LD50. H. & E. x 210.EFFECTS OF DMN AND NMU IN EUROPEAN HAMSTERS
FIG. 5. This carcinosarcoma was identified in a female European hamster 16 weeks after
beginning injections with 0-2 ofthe NMU LD50. H. & E. x 150.
were highly pleomorphic with accentuated
mitotic activity surrounded small blood-
filled vessels. In 6 animals angiosarco-
mata of both the liver and the kidney
were identified.
Nitrosomethylurea (NMU)
TheTable alsosummarizestheresultsof
NMU treatment. As thedosagedecreased,
there was a statistically significant in-
crease in survival (P < 0.05).
Repeated injections of the carcinogen
always produced inflammation at the
site of administration, and in most cases
a localized tumour developed. The latter
was first observed 9 weeks after the initial
injection in a male of the 0-2 of the
LD50 dosage group. The histology of
these tumours showed subcutaneous pleo-
morphic fibrosarcomata (Fig. 3) (24),
epidermal squamous cell carcinomata (Fig.
4) (7) and carcinosarcomata (Fig. 5) (5).
In one hamster, a neurofibrosarcoma was
identified at the site of administration.
DISCUSSION
DMN and NMU are presumed to act
through the same metabolic pathway
(Magee, 1973), but have been shown to
produce tumours of different origins and
sites. This may be due to the chemical
instability of NMU and its tendency to
degenerate rapidly at the site ofinjection,
whereas DMN requires the action of an
enzyme system for its decomposition.
These properties are exhibited here and
also in the Syrian golden hamster (Haas,
Kruger and Mohr, 1973) and in rats
(Druckrey et al., 1967).
As in mice (Takayama and Oota,
1963; Toth, Magee and Shubik, 1964),
rats (Druckrey et al., 1967) and Syrian
golden hamsters (Haas et al., 1973;
Stenback et al., 1973), DMN given over a
long period of time to the European
hamster proved to be primarily a car-
cinogen of the liver, affecting especially
the vascular, hepatocellular and in a few
cases the cholangiocellular tissues. More-
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over, this carcinogen appears to show a
high affinity for the vascular tissue as this
was the most sensitive in the liver and the
sole tissue affected in the kidney in these
studies. A predominant vascular cyto-
trophy was also reported for mice (Cardesa
et at., 1973) and Syrian golden hamsters
(Stenback et at., 1973). Renal angio-
sarcomata were reported in rats treated
with DMN (Hard and Butler, 1971), but
the vascular nature here could often be
ascertained ultrastructurally whereas in
the European hamsters these tumours
seemed to be of a well-defined vascular
structure, even when seen only with the
light microscope.
The effects of NMU were localized.
It should be noted that although the
carcinogen was injected subcutaneously,
epidermal carcinomata evolved, which is
in contrast to the results reported for the
Syrian golden hamster (Haas et al., 1973).
Possibly, these carcinomata, as well as
the epidermal parts of the carcino-
sarcomata, are the products of a reaction
following initial inflammation, regenera-
tion, disturbed regeneration and finally
transformation.
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